nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—TOP1—prostate gland—urinary bladder cancer	0.0316	0.248	CbGeAlD
Sodium stibogluconate—TOP1—seminal vesicle—urinary bladder cancer	0.0268	0.21	CbGeAlD
Sodium stibogluconate—TOP1—smooth muscle tissue—urinary bladder cancer	0.0224	0.175	CbGeAlD
Sodium stibogluconate—TOP1—urethra—urinary bladder cancer	0.0212	0.166	CbGeAlD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—BIRC3—urinary bladder cancer	0.0168	0.138	CbGpPWpGaD
Sodium stibogluconate—TOP1—vagina—urinary bladder cancer	0.0156	0.122	CbGeAlD
Sodium stibogluconate—TOP1—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.0103	0.0848	CbGpPWpGaD
Sodium stibogluconate—TOP1—lymph node—urinary bladder cancer	0.0101	0.0791	CbGeAlD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—FAS—urinary bladder cancer	0.00806	0.0663	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.00725	0.0597	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00553	0.0455	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.0055	0.0452	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.00443	0.0364	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.00352	0.029	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.00346	0.0285	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—TNF—urinary bladder cancer	0.00342	0.0282	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TYMS—urinary bladder cancer	0.00332	0.0273	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.00328	0.027	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.00306	0.0252	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—FAS—urinary bladder cancer	0.00294	0.0242	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.00271	0.0223	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.0027	0.0222	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.00268	0.0221	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—CDK4—urinary bladder cancer	0.00259	0.0213	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.00235	0.0194	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PPARG—urinary bladder cancer	0.00235	0.0194	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.00232	0.0191	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.00197	0.0162	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.00193	0.0159	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.00174	0.0143	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.00168	0.0139	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.00168	0.0138	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PTEN—urinary bladder cancer	0.00161	0.0133	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.0016	0.0132	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.00156	0.0128	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—EP300—urinary bladder cancer	0.00154	0.0127	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.0014	0.0115	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.00137	0.0112	CbGpPWpGaD
Sodium stibogluconate—Sepsis—Epirubicin—urinary bladder cancer	0.00132	0.00175	CcSEcCtD
Sodium stibogluconate—Tachycardia—Thiotepa—urinary bladder cancer	0.00131	0.00175	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.0013	0.0107	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.00129	0.0106	CbGpPWpGaD
Sodium stibogluconate—Vision blurred—Fluorouracil—urinary bladder cancer	0.00128	0.00171	CcSEcCtD
Sodium stibogluconate—Anorexia—Thiotepa—urinary bladder cancer	0.00128	0.00171	CcSEcCtD
Sodium stibogluconate—Phlebitis—Epirubicin—urinary bladder cancer	0.00128	0.0017	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Methotrexate—urinary bladder cancer	0.00127	0.0017	CcSEcCtD
Sodium stibogluconate—Flatulence—Cisplatin—urinary bladder cancer	0.00127	0.00169	CcSEcCtD
Sodium stibogluconate—Sepsis—Doxorubicin—urinary bladder cancer	0.00122	0.00162	CcSEcCtD
Sodium stibogluconate—Vision blurred—Cisplatin—urinary bladder cancer	0.00122	0.00162	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.00121	0.00162	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Thiotepa—urinary bladder cancer	0.00121	0.00161	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.0012	0.0016	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Epirubicin—urinary bladder cancer	0.00119	0.00159	CcSEcCtD
Sodium stibogluconate—Phlebitis—Doxorubicin—urinary bladder cancer	0.00118	0.00157	CcSEcCtD
Sodium stibogluconate—Convulsion—Fluorouracil—urinary bladder cancer	0.00118	0.00157	CcSEcCtD
Sodium stibogluconate—Chest pain—Gemcitabine—urinary bladder cancer	0.00118	0.00157	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Thiotepa—urinary bladder cancer	0.00117	0.00155	CcSEcCtD
Sodium stibogluconate—Chest pain—Fluorouracil—urinary bladder cancer	0.00116	0.00154	CcSEcCtD
Sodium stibogluconate—Fatigue—Thiotepa—urinary bladder cancer	0.00116	0.00154	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Etoposide—urinary bladder cancer	0.00116	0.00154	CcSEcCtD
Sodium stibogluconate—Renal impairment—Epirubicin—urinary bladder cancer	0.00116	0.00154	CcSEcCtD
Sodium stibogluconate—Constipation—Thiotepa—urinary bladder cancer	0.00115	0.00153	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.00115	0.00944	CbGpPWpGaD
Sodium stibogluconate—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00113	0.0015	CcSEcCtD
Sodium stibogluconate—Oedema—Gemcitabine—urinary bladder cancer	0.00113	0.0015	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.00112	0.0015	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.00112	0.0015	CcSEcCtD
Sodium stibogluconate—Infection—Gemcitabine—urinary bladder cancer	0.00112	0.00149	CcSEcCtD
Sodium stibogluconate—Irritability—Methotrexate—urinary bladder cancer	0.00112	0.00149	CcSEcCtD
Sodium stibogluconate—Convulsion—Cisplatin—urinary bladder cancer	0.00112	0.00149	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00111	0.00148	CcSEcCtD
Sodium stibogluconate—Oedema—Fluorouracil—urinary bladder cancer	0.00111	0.00148	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Epirubicin—urinary bladder cancer	0.0011	0.00147	CcSEcCtD
Sodium stibogluconate—Infection—Fluorouracil—urinary bladder cancer	0.0011	0.00147	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Doxorubicin—urinary bladder cancer	0.0011	0.00147	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TP53—urinary bladder cancer	0.0011	0.00906	CbGpPWpGaD
Sodium stibogluconate—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.0011	0.00146	CcSEcCtD
Sodium stibogluconate—Anxiety—Cisplatin—urinary bladder cancer	0.00109	0.00146	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00109	0.00145	CcSEcCtD
Sodium stibogluconate—Tachycardia—Fluorouracil—urinary bladder cancer	0.00108	0.00144	CcSEcCtD
Sodium stibogluconate—Anorexia—Gemcitabine—urinary bladder cancer	0.00108	0.00143	CcSEcCtD
Sodium stibogluconate—Renal impairment—Doxorubicin—urinary bladder cancer	0.00107	0.00142	CcSEcCtD
Sodium stibogluconate—Urticaria—Thiotepa—urinary bladder cancer	0.00107	0.00142	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Thiotepa—urinary bladder cancer	0.00106	0.00141	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Thiotepa—urinary bladder cancer	0.00106	0.00141	CcSEcCtD
Sodium stibogluconate—Anorexia—Fluorouracil—urinary bladder cancer	0.00106	0.00141	CcSEcCtD
Sodium stibogluconate—Hypotension—Gemcitabine—urinary bladder cancer	0.00106	0.00141	CcSEcCtD
Sodium stibogluconate—Oedema—Cisplatin—urinary bladder cancer	0.00105	0.0014	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00105	0.0014	CcSEcCtD
Sodium stibogluconate—Infection—Cisplatin—urinary bladder cancer	0.00105	0.00139	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Etoposide—urinary bladder cancer	0.00104	0.00138	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.00104	0.00138	CcSEcCtD
Sodium stibogluconate—Hypotension—Fluorouracil—urinary bladder cancer	0.00104	0.00138	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.00103	0.00137	CcSEcCtD
Sodium stibogluconate—Tachycardia—Cisplatin—urinary bladder cancer	0.00103	0.00137	CcSEcCtD
Sodium stibogluconate—Convulsion—Etoposide—urinary bladder cancer	0.00102	0.00136	CcSEcCtD
Sodium stibogluconate—Dehydration—Epirubicin—urinary bladder cancer	0.00102	0.00136	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.00102	0.00136	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00102	0.00136	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00101	0.00135	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00101	0.00134	CcSEcCtD
Sodium stibogluconate—Chest pain—Etoposide—urinary bladder cancer	0.00101	0.00134	CcSEcCtD
Sodium stibogluconate—Anorexia—Cisplatin—urinary bladder cancer	0.001	0.00134	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Epirubicin—urinary bladder cancer	0.001	0.00133	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000997	0.00133	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00099	0.00132	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000989	0.00132	CcSEcCtD
Sodium stibogluconate—Hypotension—Cisplatin—urinary bladder cancer	0.000984	0.00131	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000982	0.00131	CcSEcCtD
Sodium stibogluconate—Fatigue—Gemcitabine—urinary bladder cancer	0.000974	0.0013	CcSEcCtD
Sodium stibogluconate—Constipation—Gemcitabine—urinary bladder cancer	0.000966	0.00129	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000966	0.00129	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000965	0.00128	CcSEcCtD
Sodium stibogluconate—Asthenia—Thiotepa—urinary bladder cancer	0.000964	0.00128	CcSEcCtD
Sodium stibogluconate—Infection—Etoposide—urinary bladder cancer	0.000958	0.00128	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Epirubicin—urinary bladder cancer	0.000957	0.00128	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000954	0.00127	CcSEcCtD
Sodium stibogluconate—Dysphagia—Epirubicin—urinary bladder cancer	0.000951	0.00127	CcSEcCtD
Sodium stibogluconate—Pruritus—Thiotepa—urinary bladder cancer	0.00095	0.00127	CcSEcCtD
Sodium stibogluconate—Dehydration—Doxorubicin—urinary bladder cancer	0.000947	0.00126	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Cisplatin—urinary bladder cancer	0.000946	0.00126	CcSEcCtD
Sodium stibogluconate—Tachycardia—Etoposide—urinary bladder cancer	0.000942	0.00125	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Cisplatin—urinary bladder cancer	0.000939	0.00125	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000933	0.00124	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000926	0.00123	CcSEcCtD
Sodium stibogluconate—Anorexia—Etoposide—urinary bladder cancer	0.00092	0.00122	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Thiotepa—urinary bladder cancer	0.000919	0.00122	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Cisplatin—urinary bladder cancer	0.000915	0.00122	CcSEcCtD
Sodium stibogluconate—Bronchitis—Epirubicin—urinary bladder cancer	0.000915	0.00122	CcSEcCtD
Sodium stibogluconate—Hypotension—Etoposide—urinary bladder cancer	0.000901	0.0012	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000893	0.00119	CcSEcCtD
Sodium stibogluconate—Renal failure—Methotrexate—urinary bladder cancer	0.000891	0.00119	CcSEcCtD
Sodium stibogluconate—Dizziness—Thiotepa—urinary bladder cancer	0.000888	0.00118	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000886	0.00118	CcSEcCtD
Sodium stibogluconate—Urticaria—Fluorouracil—urinary bladder cancer	0.000882	0.00118	CcSEcCtD
Sodium stibogluconate—Dysphagia—Doxorubicin—urinary bladder cancer	0.00088	0.00117	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000878	0.00117	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Etoposide—urinary bladder cancer	0.000866	0.00115	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Etoposide—urinary bladder cancer	0.00086	0.00115	CcSEcCtD
Sodium stibogluconate—Vomiting—Thiotepa—urinary bladder cancer	0.000854	0.00114	CcSEcCtD
Sodium stibogluconate—Rash—Thiotepa—urinary bladder cancer	0.000847	0.00113	CcSEcCtD
Sodium stibogluconate—Bronchitis—Doxorubicin—urinary bladder cancer	0.000846	0.00113	CcSEcCtD
Sodium stibogluconate—Dermatitis—Thiotepa—urinary bladder cancer	0.000846	0.00113	CcSEcCtD
Sodium stibogluconate—Headache—Thiotepa—urinary bladder cancer	0.000841	0.00112	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Etoposide—urinary bladder cancer	0.000839	0.00112	CcSEcCtD
Sodium stibogluconate—Renal failure—Epirubicin—urinary bladder cancer	0.000833	0.00111	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Cisplatin—urinary bladder cancer	0.000832	0.00111	CcSEcCtD
Sodium stibogluconate—Fatigue—Etoposide—urinary bladder cancer	0.000832	0.00111	CcSEcCtD
Sodium stibogluconate—Constipation—Etoposide—urinary bladder cancer	0.000825	0.0011	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000818	0.00109	CcSEcCtD
Sodium stibogluconate—Asthenia—Gemcitabine—urinary bladder cancer	0.000811	0.00108	CcSEcCtD
Sodium stibogluconate—Pruritus—Gemcitabine—urinary bladder cancer	0.000799	0.00106	CcSEcCtD
Sodium stibogluconate—Nausea—Thiotepa—urinary bladder cancer	0.000798	0.00106	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000789	0.00105	CcSEcCtD
Sodium stibogluconate—Pruritus—Fluorouracil—urinary bladder cancer	0.000786	0.00105	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000776	0.00103	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000773	0.00103	CcSEcCtD
Sodium stibogluconate—Renal failure—Doxorubicin—urinary bladder cancer	0.000771	0.00103	CcSEcCtD
Sodium stibogluconate—Urticaria—Etoposide—urinary bladder cancer	0.000766	0.00102	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Etoposide—urinary bladder cancer	0.000763	0.00102	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Etoposide—urinary bladder cancer	0.000763	0.00102	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00076	0.00101	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000757	0.00101	CcSEcCtD
Sodium stibogluconate—Asthenia—Cisplatin—urinary bladder cancer	0.000756	0.00101	CcSEcCtD
Sodium stibogluconate—Dizziness—Fluorouracil—urinary bladder cancer	0.000735	0.000978	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Cisplatin—urinary bladder cancer	0.00072	0.00096	CcSEcCtD
Sodium stibogluconate—Vomiting—Gemcitabine—urinary bladder cancer	0.000718	0.000957	CcSEcCtD
Sodium stibogluconate—Rash—Gemcitabine—urinary bladder cancer	0.000712	0.000949	CcSEcCtD
Sodium stibogluconate—Dermatitis—Gemcitabine—urinary bladder cancer	0.000712	0.000948	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Etoposide—urinary bladder cancer	0.000711	0.000947	CcSEcCtD
Sodium stibogluconate—Headache—Gemcitabine—urinary bladder cancer	0.000708	0.000943	CcSEcCtD
Sodium stibogluconate—Vomiting—Fluorouracil—urinary bladder cancer	0.000706	0.000941	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000701	0.000933	CcSEcCtD
Sodium stibogluconate—Rash—Fluorouracil—urinary bladder cancer	0.0007	0.000933	CcSEcCtD
Sodium stibogluconate—Dermatitis—Fluorouracil—urinary bladder cancer	0.0007	0.000932	CcSEcCtD
Sodium stibogluconate—Headache—Fluorouracil—urinary bladder cancer	0.000696	0.000927	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Methotrexate—urinary bladder cancer	0.000693	0.000923	CcSEcCtD
Sodium stibogluconate—Asthenia—Etoposide—urinary bladder cancer	0.000692	0.000922	CcSEcCtD
Sodium stibogluconate—Pruritus—Etoposide—urinary bladder cancer	0.000683	0.000909	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Epirubicin—urinary bladder cancer	0.00068	0.000906	CcSEcCtD
Sodium stibogluconate—Nausea—Gemcitabine—urinary bladder cancer	0.000671	0.000894	CcSEcCtD
Sodium stibogluconate—Vomiting—Cisplatin—urinary bladder cancer	0.00067	0.000892	CcSEcCtD
Sodium stibogluconate—Vision blurred—Methotrexate—urinary bladder cancer	0.000667	0.000889	CcSEcCtD
Sodium stibogluconate—Rash—Cisplatin—urinary bladder cancer	0.000664	0.000884	CcSEcCtD
Sodium stibogluconate—Dermatitis—Cisplatin—urinary bladder cancer	0.000663	0.000884	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Etoposide—urinary bladder cancer	0.00066	0.000879	CcSEcCtD
Sodium stibogluconate—Nausea—Fluorouracil—urinary bladder cancer	0.00066	0.000879	CcSEcCtD
Sodium stibogluconate—Flatulence—Epirubicin—urinary bladder cancer	0.000653	0.00087	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Epirubicin—urinary bladder cancer	0.000649	0.000864	CcSEcCtD
Sodium stibogluconate—Dizziness—Etoposide—urinary bladder cancer	0.000638	0.00085	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000629	0.000838	CcSEcCtD
Sodium stibogluconate—Nausea—Cisplatin—urinary bladder cancer	0.000625	0.000833	CcSEcCtD
Sodium stibogluconate—Vision blurred—Epirubicin—urinary bladder cancer	0.000624	0.000832	CcSEcCtD
Sodium stibogluconate—Convulsion—Methotrexate—urinary bladder cancer	0.000613	0.000817	CcSEcCtD
Sodium stibogluconate—Vomiting—Etoposide—urinary bladder cancer	0.000613	0.000817	CcSEcCtD
Sodium stibogluconate—Rash—Etoposide—urinary bladder cancer	0.000608	0.00081	CcSEcCtD
Sodium stibogluconate—Dermatitis—Etoposide—urinary bladder cancer	0.000608	0.000809	CcSEcCtD
Sodium stibogluconate—Headache—Etoposide—urinary bladder cancer	0.000604	0.000805	CcSEcCtD
Sodium stibogluconate—Flatulence—Doxorubicin—urinary bladder cancer	0.000604	0.000805	CcSEcCtD
Sodium stibogluconate—Chest pain—Methotrexate—urinary bladder cancer	0.000603	0.000803	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Doxorubicin—urinary bladder cancer	0.0006	0.0008	CcSEcCtD
Sodium stibogluconate—Syncope—Epirubicin—urinary bladder cancer	0.000594	0.000791	CcSEcCtD
Sodium stibogluconate—Palpitations—Epirubicin—urinary bladder cancer	0.000586	0.00078	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000582	0.000776	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000578	0.00077	CcSEcCtD
Sodium stibogluconate—Vision blurred—Doxorubicin—urinary bladder cancer	0.000578	0.00077	CcSEcCtD
Sodium stibogluconate—Convulsion—Epirubicin—urinary bladder cancer	0.000574	0.000765	CcSEcCtD
Sodium stibogluconate—Infection—Methotrexate—urinary bladder cancer	0.000574	0.000765	CcSEcCtD
Sodium stibogluconate—Nausea—Etoposide—urinary bladder cancer	0.000573	0.000763	CcSEcCtD
Sodium stibogluconate—Chest pain—Epirubicin—urinary bladder cancer	0.000564	0.000751	CcSEcCtD
Sodium stibogluconate—Anxiety—Epirubicin—urinary bladder cancer	0.000562	0.000749	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000559	0.000744	CcSEcCtD
Sodium stibogluconate—Anorexia—Methotrexate—urinary bladder cancer	0.000551	0.000734	CcSEcCtD
Sodium stibogluconate—Syncope—Doxorubicin—urinary bladder cancer	0.00055	0.000732	CcSEcCtD
Sodium stibogluconate—Palpitations—Doxorubicin—urinary bladder cancer	0.000542	0.000722	CcSEcCtD
Sodium stibogluconate—Oedema—Epirubicin—urinary bladder cancer	0.000541	0.00072	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000541	0.00072	CcSEcCtD
Sodium stibogluconate—Hypotension—Methotrexate—urinary bladder cancer	0.00054	0.000719	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000539	0.000718	CcSEcCtD
Sodium stibogluconate—Infection—Epirubicin—urinary bladder cancer	0.000537	0.000716	CcSEcCtD
Sodium stibogluconate—Shock—Epirubicin—urinary bladder cancer	0.000532	0.000709	CcSEcCtD
Sodium stibogluconate—Convulsion—Doxorubicin—urinary bladder cancer	0.000531	0.000708	CcSEcCtD
Sodium stibogluconate—Tachycardia—Epirubicin—urinary bladder cancer	0.000528	0.000703	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000523	0.000696	CcSEcCtD
Sodium stibogluconate—Chest pain—Doxorubicin—urinary bladder cancer	0.000522	0.000695	CcSEcCtD
Sodium stibogluconate—Anxiety—Doxorubicin—urinary bladder cancer	0.00052	0.000693	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Methotrexate—urinary bladder cancer	0.000519	0.000691	CcSEcCtD
Sodium stibogluconate—Anorexia—Epirubicin—urinary bladder cancer	0.000515	0.000687	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Methotrexate—urinary bladder cancer	0.000515	0.000686	CcSEcCtD
Sodium stibogluconate—Hypotension—Epirubicin—urinary bladder cancer	0.000505	0.000673	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Methotrexate—urinary bladder cancer	0.000502	0.000669	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.0005	0.000666	CcSEcCtD
Sodium stibogluconate—Oedema—Doxorubicin—urinary bladder cancer	0.0005	0.000666	CcSEcCtD
Sodium stibogluconate—Fatigue—Methotrexate—urinary bladder cancer	0.000498	0.000664	CcSEcCtD
Sodium stibogluconate—Infection—Doxorubicin—urinary bladder cancer	0.000497	0.000662	CcSEcCtD
Sodium stibogluconate—Shock—Doxorubicin—urinary bladder cancer	0.000492	0.000656	CcSEcCtD
Sodium stibogluconate—Tachycardia—Doxorubicin—urinary bladder cancer	0.000488	0.00065	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Epirubicin—urinary bladder cancer	0.000486	0.000647	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000484	0.000644	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Epirubicin—urinary bladder cancer	0.000482	0.000642	CcSEcCtD
Sodium stibogluconate—Anorexia—Doxorubicin—urinary bladder cancer	0.000477	0.000635	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000473	0.000629	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Epirubicin—urinary bladder cancer	0.00047	0.000626	CcSEcCtD
Sodium stibogluconate—Hypotension—Doxorubicin—urinary bladder cancer	0.000468	0.000623	CcSEcCtD
Sodium stibogluconate—Fatigue—Epirubicin—urinary bladder cancer	0.000466	0.000621	CcSEcCtD
Sodium stibogluconate—Constipation—Epirubicin—urinary bladder cancer	0.000462	0.000616	CcSEcCtD
Sodium stibogluconate—Urticaria—Methotrexate—urinary bladder cancer	0.000459	0.000611	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Methotrexate—urinary bladder cancer	0.000457	0.000608	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Methotrexate—urinary bladder cancer	0.000457	0.000608	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000449	0.000598	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000446	0.000594	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000442	0.000589	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000435	0.000579	CcSEcCtD
Sodium stibogluconate—Fatigue—Doxorubicin—urinary bladder cancer	0.000431	0.000575	CcSEcCtD
Sodium stibogluconate—Urticaria—Epirubicin—urinary bladder cancer	0.00043	0.000572	CcSEcCtD
Sodium stibogluconate—Constipation—Doxorubicin—urinary bladder cancer	0.000428	0.00057	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Epirubicin—urinary bladder cancer	0.000427	0.000569	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Epirubicin—urinary bladder cancer	0.000427	0.000569	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000426	0.000567	CcSEcCtD
Sodium stibogluconate—Asthenia—Methotrexate—urinary bladder cancer	0.000415	0.000552	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000409	0.000545	CcSEcCtD
Sodium stibogluconate—Pruritus—Methotrexate—urinary bladder cancer	0.000409	0.000545	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000398	0.000531	CcSEcCtD
Sodium stibogluconate—Urticaria—Doxorubicin—urinary bladder cancer	0.000397	0.000529	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000396	0.000527	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000396	0.000527	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Methotrexate—urinary bladder cancer	0.000395	0.000527	CcSEcCtD
Sodium stibogluconate—Asthenia—Epirubicin—urinary bladder cancer	0.000388	0.000517	CcSEcCtD
Sodium stibogluconate—Pruritus—Epirubicin—urinary bladder cancer	0.000383	0.00051	CcSEcCtD
Sodium stibogluconate—Dizziness—Methotrexate—urinary bladder cancer	0.000382	0.000509	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Epirubicin—urinary bladder cancer	0.00037	0.000493	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000369	0.000491	CcSEcCtD
Sodium stibogluconate—Vomiting—Methotrexate—urinary bladder cancer	0.000367	0.000489	CcSEcCtD
Sodium stibogluconate—Rash—Methotrexate—urinary bladder cancer	0.000364	0.000485	CcSEcCtD
Sodium stibogluconate—Dermatitis—Methotrexate—urinary bladder cancer	0.000364	0.000485	CcSEcCtD
Sodium stibogluconate—Headache—Methotrexate—urinary bladder cancer	0.000362	0.000482	CcSEcCtD
Sodium stibogluconate—Asthenia—Doxorubicin—urinary bladder cancer	0.000359	0.000478	CcSEcCtD
Sodium stibogluconate—Dizziness—Epirubicin—urinary bladder cancer	0.000358	0.000476	CcSEcCtD
Sodium stibogluconate—Pruritus—Doxorubicin—urinary bladder cancer	0.000354	0.000472	CcSEcCtD
Sodium stibogluconate—Vomiting—Epirubicin—urinary bladder cancer	0.000344	0.000458	CcSEcCtD
Sodium stibogluconate—Nausea—Methotrexate—urinary bladder cancer	0.000343	0.000457	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000342	0.000456	CcSEcCtD
Sodium stibogluconate—Rash—Epirubicin—urinary bladder cancer	0.000341	0.000454	CcSEcCtD
Sodium stibogluconate—Dermatitis—Epirubicin—urinary bladder cancer	0.000341	0.000454	CcSEcCtD
Sodium stibogluconate—Headache—Epirubicin—urinary bladder cancer	0.000339	0.000451	CcSEcCtD
Sodium stibogluconate—Dizziness—Doxorubicin—urinary bladder cancer	0.000331	0.000441	CcSEcCtD
Sodium stibogluconate—Nausea—Epirubicin—urinary bladder cancer	0.000321	0.000428	CcSEcCtD
Sodium stibogluconate—Vomiting—Doxorubicin—urinary bladder cancer	0.000318	0.000424	CcSEcCtD
Sodium stibogluconate—Rash—Doxorubicin—urinary bladder cancer	0.000315	0.00042	CcSEcCtD
Sodium stibogluconate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000315	0.00042	CcSEcCtD
Sodium stibogluconate—Headache—Doxorubicin—urinary bladder cancer	0.000313	0.000418	CcSEcCtD
Sodium stibogluconate—Nausea—Doxorubicin—urinary bladder cancer	0.000297	0.000396	CcSEcCtD
